P2.03-021 A Phase I Study Evaluating the Combination of Afatinib, Carboplatin and Pemetrexed after Failure of 1st Generation EGFR-TKIs

Authors :: Osamu Ishimoto
Hirohisa Yoshizawa
Satoshi Watanabe
Ai Masumoto
Toshihiro Nukiwa
Kazuhiko Kobayashi
Y. Kawashima
Ou Yamaguchi
Yuri Maeno
Shunichi Sugawara
Source :: Journal of Thoracic Oncology. 12:S2135
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Afatinib
Carboplatin
Phase i study
Egfr tki
chemistry.chemical_compound
Pemetrexed
chemistry
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools